When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Strongbridge Biopharma is looking at a major inflection year in 2021.
In early January, the company provided strong preliminary fourth-quarter guidance but the major catalyst this year is the potential FDA approval of RECORLEV.
We size up this small cap biopharma's prospects this year in the paragraphs below.